Asia - Pacific Electrophysiology - Growth, Trends and Forecasts 2017 - 2022

  • ID: 4387345
  • Report
  • Region: Asia
  • 134 pages
  • Mordor Intelligence
1 of 4
Asia-Pacific electrophysiology (EP) market, is set to experience rapid growth in value over the coming years, climbing from approximately $0.62 billion in 2014 to $0.89 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 9%.

The Asia-Pacific electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems.

The growth of the Asia- Pacific Electrophysiology market is driven by several factors, the most important of which is the technological innovations. Technological innovations and advancements have led to the introduction of new products . The other factors promoting the growth of the market are increasing incidences of chronic diseases, , ease of use and interpretation of medical devices. Factors constraining the growth of the market include reimbursement issues, high cost of the medical devices .Emerging economies, Public awareness for cardiac disease are the major opportunities in the market.

The report segments the market by types( Electrophysiology monitoring devices, Treatment devices) and based on geography(India, China, Japan)Asia-Pacific shows very potential market due to increasing technological innovations, and increasing per capita income and growing economy.

Major companies discussed in this report with their profile and relevant information from market perspective are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic Inc., Microport

What makes our report unique??

1) An extensive research study on the Electrophysiology market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the wearable electronics.

2) We provide the longest segmentation of the market based on products, technology, components, form factor, products application, industry verticals, and geography.

3) This report gives a birds eye-view of the market competitive landscape which includes mergers & acquisitions, collaborations., new product launches and key players in the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report description
1.2 Research methodology
2. Executive summary
3. MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SIZE AND FORECASTS
3.3 MARKET DYNAMICS
3.3.1 MARKET DRIVERS
3.3.1.1 RAPIDLY INCREASING AGED POPULTAION
3.3.1.2 INCREASING CASES OF CARDIAC DISEASES
3.3.1.3 TECHNOLOGICAL ADVANCEMENTS
3.3.2 MARKET RESTRAINTS
3.3.2.1 HIGH COST OF TREATMENT
3.3.2.2 REGULATORY ISSUES
3.3.2.3 PATIENT PROTECTION AND AFFORDABLE CARE ACT
3.3.2.4 INCREASING HEALTHCARE EXPENDITURE
3.3.2.5 RISING ADOPTION OF ABLATION TECHNIQUES
3.3.3 OPPORTUNITIES
3.3.3.1 EMERGING ECONOMIES
3.3.3.2 PUBLIC AWARENESS FOR CARDIAC DISEASES
3.3.3.3 HUGE SCOPE FOR CONSOLIDATION
3.3.4 PORTER'S FIVE FORCE ANALYSIS
3.3.4.1 BARGAINING POWER OF SUPPLIERS
3.3.4.2 BARGAINING POWER OF BUYERS
3.3.4.3 THREAT OF SUBSTITUTES
3.3.4.4 THREAT FROM NEW ENTRANT
3.3.4.5 COMPETITIVE RIVALRY
4. Market segmentation
4.1 Market segmentation,by type of products
4.1.1 Electrophysiology monitoring devices
4.1.1.1 Electrocardiograph (ECG)
4.1.1.2 Electroencephalograph (EEG)
4.1.1.3 Electrocorticograph (ECOG)
4.1.1.4 Electromyograph (EMG)
4.1.1.5 Electroretinograph (ERG)
4.1.1.6 Electrooculograph (EOG)
4.1.1.7 Holter monitoring devices
4.1.1.8 X-ray systems
4.1.1.9 Imaging and 3d mapping systems
4.1.1.10 Diagnostic electrophysiology catheters
4.1.2 Electrophysiology treatment devices
4.1.2.1 Implantable cardioverter defibrillators (ICDS)
4.1.2.2 Pacemakers
4.1.2.3 Cardiac resynchronization therapy devices (CRTS)
4.1.2.4 Catheters
4.1.2.4.1 Radiofrequency electrophysiology ablation catheters
4.1.2.4.2 Cryoablation electrophysiology catheters
4.1.2.4.3 Laser ablation catheters
4.1.2.4.4 Microwave ablation catheters
4.2 Electrophysiology treatment devices, by geography
4.2.1 India
4.2.2 China
4.2.3 Japan
4.2.4 ROA
5. Competitive Landscape
5.1 Mergers/acquisitions
5.2 Collaborations/partnerships
5.3 Product launches/developments
6. COMPANY PROFILES
6.1 Biosense webster, inc.
6.2 St. Jude medical, inc.
6.3 Japan lifeline co., ltd.
6.4 Biotronik se & co. Kg
6.5 Boston scientific corporation
6.6 Medtronic, inc.
6.7 C. R. Bard, inc.
7. Appendix
7.1. Abbreviations
7.2. Sources
7.3. Bibliography
7.4. Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll